[What do we know about the mechanisms of the time factor in oncological therapy?]

Strahlenther Onkol. 2000 Oct;176(10):443-7. doi: 10.1007/pl00002307.
[Article in German]

Abstract

Background: Experimental studies and prospective randomized clinical trials have demonstrated a detrimental effect of prolongation of overall treatment time on local tumor control.

Methods: In a brief review of the literature, possible mechanisms of the time factor are discussed.

Results and conclusions: The mechanisms of the time factor in cancer treatment are complex and, at present, not fully understood. In experimental tumors, rapid proliferation of clonogenic cells during fractionated irradiation and treatment gaps has been determined as a major cause of the time factor in radiotherapy. Also, chemotherapy can stimulate repopulation of experimental tumors by clonogenic cells. Besides repopulation of clonogenic tumor cells, other factors such as the deterioration of the tumor vasculature with increasing tumor hypoxia might contribute to the time factor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / radiotherapy
  • Cell Hypoxia
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Dose Fractionation, Radiation
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neoplasms / blood supply
  • Neoplasms / pathology
  • Neoplasms / radiotherapy*
  • Neoplasms, Experimental / pathology
  • Neoplasms, Experimental / radiotherapy
  • Radiotherapy Dosage
  • Time Factors

Substances

  • Biomarkers, Tumor